Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)

NCT01713855 is registered in ClinicalTrials.gov with Neufeld, Ellis J, MD, PhD as lead sponsor.

NCT NCT01713855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01713855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)
Lead sponsor
Neufeld, Ellis J, MD, PhD
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2004
Completion date
March 31, 2006
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic thrombocytopenic purpura, immune thrombocytopenic purpura